Related Experiment Video
Updated: Jun 3, 2026
09:23
Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Metal ions affecting the kidney
1Division of Toxicology and Environmental Medicine, Agency for Toxic Substances and Disease Registry, Atlanta GA 30341, USA. bfowler@cdc.gov
Metal Ions in Life Sciences
|April 9, 2011
Summary
This study summarizes metal/metalloid nephrotoxicity, including exposure routes and renal cell uptake mechanisms. It highlights biomarkers for early kidney cell injury detection, even with mixed exposures.
Area of Science:
- Toxicology
- Nephrology
- Environmental Health
Background:
- Metals and metalloids can cause kidney damage (nephrotoxicity).
- Exposure can occur through various routes, and these substances can enter renal cells.
- Nanomaterials may alter these toxicological processes.
Purpose of the Study:
- To summarize the nephrotoxic effects of metals/metalloids.
- To discuss exposure routes, cellular uptake, and nanomaterial impact.
- To emphasize early detection of kidney cell injury using biomarkers.
Main Methods:
- Review of existing literature on metal/metalloid nephrotoxicity.
- Analysis of mechanisms of renal cell uptake.
- Discussion of biomarker applications for early injury detection.
Main Results:
- Metals/metalloids exhibit toxicity to specific kidney cell types.
- Biomarkers can detect kidney cell injury before clinical symptoms like end-stage renal disease.
- Interactions in mixed exposures are relevant for biomarker application.
Conclusions:
- Understanding metal/metalloid nephrotoxicity is crucial.
- Biomarkers offer a promising approach for early diagnosis of kidney damage.
- Further research into mixed exposures and nanomaterial effects is warranted.
More Related Videos
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...